You are here: Industry Insights > Japan

News List

UK and Japan partner on treatments for degenerative diseases pharmaceutical-technology
January 15, 2019
Medical researchers in the UK and Japan are set to work together on advancing research aimed at developing treatments for chronic degenerative and incurable diseases, including diabetes and heart disease.....
Sun Pharma acquires Japan’s Pola Pharma expressbpd
January 04, 2019
To strengthen its presence in dermatology segment across the globe
Parle Global Technologies, India, in JV with Freund Corporation, Japan expressbpd
December 13, 2018
The aim of the JV is to initially launch the series of dry granulation systems with unique design and construction philosophy
Mundipharma to distribute Norspan in Japan expressbpd
December 12, 2018
Norspan is indicated for the relief of chronic pain associated with osteoarthritis and lower back pain
Sun gets dermatology portfolio, 2 plants in Japan with Pola Pharma deal fiercepharma
December 10, 2018
Sun Pharma got a start in Japan when it paid Novartis nearly $300 million a couple of years ago for more than a dozen drugs the Swiss drugmaker was unloading.
Sun Pharmaceutical agrees to acquire Japan’s Pola Pharma pharmaceutical
November 29, 2018
India-based drugmaker Sun Pharmaceutical Industries has signed a definitive agreement to acquire Pola Pharma, a Japan-based pharma firm involved in the research, development, manufacture, and sale of branded and generic products......
Sun Pharma to acquire Pola Pharma in Japan expressbpd
November 26, 2018
Sun Pharmaceutical Industries including its subsidiaries and/or associate companies, announced that Sun Pharma has entered into a definitive agreement to acquire Pola Pharma, a Japanese pharmaceutical company engaged in research and development, manufactu
Mundipharma acquires rights for Invossa osteoarthritis therapy in Japan pharmaceutical-technology
November 19, 2018
Mundipharma has signed a multi-year agreement for up to $600m with Kolon Life Sciences to secure the exclusive rights for Invossa osteoarthritis therapy in Japan.
Brickell Biotech-Kaken Pharma to co-develop dermatology drug biospectrumasia
November 16, 2018
Brickell Biotech Inc., a US-based clinical-stage pharmaceutical company has signed an exclusive license and development agreement for BBI-4000
Japan conducts world’s first iPS cell transplant for Parkinson’s biospectrum
November 12, 2018
The team intends to develop a mass production system that enables the delivery of nerve cells derived from iPS cells all over the world.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page